Radiopharm Theranostics Eulerpool ニュース

Radiopharm Theranostics Eulerpool-AFX

Radiopharm Theranostics 株式ニュース

Radiopharm Theranosticsは世界中の多くのジャーナリストや投資家に注目されています。最新のRadiopharm Theranosticsニュースをここにまとめています。

• ·

  Yahoo
  Radiopharm Theranostics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
• ·

  Yahoo
  Radiopharm Theranostics Non-Executive Director Acquires 430% More Stock
• ·

  Yahoo
  Radiopharm Receives Strategic Investment for up to A$18 million
• ·

  Yahoo
  RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
• ·

  Yahoo
  Radiopharm Theranostics Full Year 2023 Earnings: AU$0.11 loss per share (vs AU$0.17 loss in FY 2022)
• ·

  Yahoo
  Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
• ·

  Yahoo
  Diamond Equity Research to Host Global Select Emerging Growth Invitational Virtual Investor Conference on June 13th, 2023
• ·

  Yahoo
  Radiopharm Theranostics Receives FDA Orphan Drug Designation for Trivehexin (RAD 301) in Pancreatic Cancer
• ·

  Yahoo
  Radiopharm Theranostics secures pivotal isotope for cancer-targeting peptide
• ·

  Yahoo
  Radiopharm Theranostics Enters Into Supply Agreement with TerThera for Terbium-161 Isotope